Illustration of a hand holding a red ribbon with blood cells in the background

Let’s unite in the fight against blood cancer

How can we make a difference this blood cancer awareness month?

Blood cancer awareness month is an ideal time to reflect on the huge burden posed by blood cancer. Globally, there were around 487,294 new cases of leukemia in 2022 alone — and 305,405 deaths (1). This makes early diagnosis and treatment more critical than ever.

Whether you are a clinical researcher, oncohematologist or data specialist, we are committed to supporting your work to advance clinical care in oncohematology. Discover how we can help take your blood cancer care and clinical research to the next level – during this blood cancer awareness month and beyond.

Reference

1. The Global Cancer Observatory https://gco.iarc.who.int/media/globocan/factsheets/cancers/36-leukaemia-fact-sheet.pdf (accessed August 8, 2024)
How Mikrogen Lab improved CML patient care

With our ipsogen BCR::ABL1 test solutions, the Mikrogen Genetic Diseases Diagnosis Center, Turkey can now offer speedy, specific and sensitive tests — significantly shortening turnaround times.

The lab also enjoys fast and easy data analysis and reporting, in line with International Scale (IS) standardization.

Volkan Baltacı, Founder of Mikrogen Genetic Diseases Diagnosis Center
Volkan Baltacı, Founder of Mikrogen Genetic Diseases Diagnosis Center
Intuitive workflow resulted in time savings and increased lab efficiency

The CARPERMOR International Reference Laboratory in Mexico achieved highly sensitive and specific quantification of BCR::ABL1 transcripts in CML clinical research.

The intuitive workflow of the BCR-ABL1 Mbcr RGQ RT-PCR Kit delivered fast, sensitive and accurate results aligned with the International Scale.

Guadalupe Ivon Padilla Maya, Jessica Alejandra Rivera Dominguez and David Palencia Céspedes, CARPERMOR International Reference Laboratory
Guadalupe Ivon Padilla Maya, Jessica Alejandra Rivera Dominguez and David Palencia Céspedes, CARPERMOR International Reference Laboratory

Test your blood cancer knowledge

Are you ready to take the oncohematology challenge? Discover how much you really know about blood cancer biomarkers and molecular testing.
Navigate the complexities of MRD monitoring with confidence

Are you struggling with the challenges of molecular MRD monitoring in AML or ALL? Join our oncohematology experts as they reveal top tips and best practices.

Watch our four-part webinar series on AML and ALL.

The power of having one oncohematology partner
We support your clinical blood cancer care and molecular research with a comprehensive assay, platform and service portfolio – from Sample to Insight.
An Adult Hipster Son And Senior Father Indoors At Home, Hugging